Pluristyx Inc., the leader in advanced induced pluripotent stem cell (iPSC) technologies, announces today the Initial Close of their Series A financing led by a global Fortune 500 company along with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results